Cerebrolysin
Also known as: FPF-1070
Clinical Status
Approved in multiple countries outside the US for stroke and TBI recovery.
Mechanism of Action
A mixture of neurotrophic peptides derived from porcine brain tissue. Mimics BDNF and NGF activity, promotes neuronal sprouting, synaptogenesis, and neuroprotection against excitotoxicity.
Dosing Defaults
Dose
5-30 mL
Frequency
5x weekly for 4 weeks
Administration
Intravenous or intramuscular injection
Timing
Morning
Food
with or without
Duration
4-week cycles
Dose range: 5-50 mL per session
Morning administration supports daytime neuroplasticity.
Side Effects
- •Dizziness
- •Headache
- •Injection site pain
- •Nausea
- •Agitation
- •Insomnia
Contraindications & Warnings
- ⚠Epilepsy
- ⚠Severe renal impairment
- •Not medical advice
- •Not FDA approved in the US
Compare
Compare Cerebrolysin with another peptide side-by-side.
Ad
Related Healing & Recovery Peptides
This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.